Atypical Antipsychotics in Children and Adolescents With Autistic and Other Pervasive Developmental Disorders
J Clin Psychiatry 2008;69(suppl 4):15-20
© Copyright 2017 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Atypical antipsychotics are emerging as the first-line pharmacologic
treatment for irritability (i.e., aggression, self-injurious behavior, and
severe tantrums) in children and adolescents with autistic and other pervasive
developmental disorders. Results from placebo-controlled and open-label
studies of clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and
aripiprazole in this subject population are reviewed. Additional
placebo-controlled trials and studies of longer-term safety and tolerability